Matthew T. Wolf, PhD (he/him/his)

Investigator
National Cancer Institute, United States

Disclosure information not submitted.

Presentation(s):

• Extracellular matrix scaffold assisted cancer vaccine enhances anti-tumor efficacy and provides long term protection

  Thursday, October 24, 2024
  9:00 AM – 9:15 AM EST

• Poster S4 - 3D MatriSpheres Recapitulate Tumor Morphology and Phenotypic Heterogeneity

  Thursday, October 24, 2024
  10:00 AM – 11:00 AM EST

• A Biologic Mesh Infused with a STING Agonist Therapeutic Cancer Vaccine Prevents Tumor Recurrence: Cancer Immunotherapy Meets Tissue Engineering

  Thursday, October 24, 2024
  2:15 PM – 2:30 PM EST

• Poster S17 - Engineering the 3D Melanoma Tumor Microenvironment In Vitro Using Extracellular Matrix Enhanced Spheroids

  Thursday, October 24, 2024
  2:45 PM – 3:45 PM EST

• Poster W16 - Investigating nanoparticle shape to overcome the lung tumor microenvironment

  Friday, October 25, 2024
  10:00 AM – 11:00 AM EST

• Material Characterization and Temporospatial Immune Response to Cryogenically Sintered Extracellular Matrix Particle Scaffolds in Volumetric Muscle Loss Injury

  Friday, October 25, 2024
  5:15 PM – 5:30 PM EST

• Branched PEGylation enhances nanoparticle delivery to tumor-associated immune cells

  Saturday, October 26, 2024
  1:30 PM – 1:45 PM EST

• Characterization of senescent stromal cells in the tumor microenvironment treated with immune checkpoint blockade

  Saturday, October 26, 2024
  12:45 PM – 1:00 PM EST